Biotech · Private company
Dendreon
Track this companyFree. Adds Dendreon to your Dealase workspace and tells you when its record changes.
Clinical trials115 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- sipuleucel-TPhase 3 · Adenocarcinoma of the ProstateClinicalTrials.gov · fetched Nov 12, 2026
- abiraterone acetatePhase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- APC8015FPhase 2 · Metastatic Androgen Independent Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- sipuleucel-TPhase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- Sipuleucel-T InjectionPhase 2 · Metastatic Castration-Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- sipuleucel-TAdvanced Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Sipuleucel-TProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate CancerPHASE1 · NOT_YET_RECRUITING · started Nov 30, 2026ClinicalTrials.gov NCT07756593 · fetched Nov 12, 2026
- Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPCPHASE2 · RECRUITING · started Dec 20, 2023ClinicalTrials.gov NCT06100705 · fetched Nov 12, 2026
- Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 12, 2023ClinicalTrials.gov NCT05806814 · fetched Nov 12, 2026
- Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TPHASE2 · RECRUITING · started Oct 2, 2023ClinicalTrials.gov NCT06134232 · fetched Nov 12, 2026
- Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 14, 2023ClinicalTrials.gov NCT05751941 · fetched Nov 12, 2026
- Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate CancerPHASE3 · COMPLETED · started Oct 18, 2018ClinicalTrials.gov NCT03686683 · fetched Nov 12, 2026
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TTERMINATED · started Oct 1, 2012ClinicalTrials.gov NCT01727154 · fetched Nov 12, 2026
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerTERMINATED · started Jan 1, 2012ClinicalTrials.gov NCT01981109 · fetched Nov 12, 2026
- Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate CancerPHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01487863 · fetched Nov 12, 2026
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerCOMPLETED · started Jan 27, 2011ClinicalTrials.gov NCT01306890 · fetched Nov 12, 2026
- Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)PHASE2 · COMPLETED · started Apr 1, 2004ClinicalTrials.gov NCT00849290 · fetched Nov 12, 2026